Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-09

Clinical Trial Update: Taurine Eye Drops May Prevent the Progression of Cataract [Phase 1, Phase 2]

View source ↗

Summary

The update reports a Phase 1/2 trial investigating taurine eye drops as a potential treatment to slow progression of cataracts, sponsored by the University of A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Taurine Eye Drops (taurine)

Snippet

Sponsor: University Of Anbar | Conditions: Cataract | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING